| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0001-7310(10)70012-0 |
| P698 | PubMed publication ID | 20492884 |
| P2093 | author name string | M Ribera | |
| J Luelmo | |||
| L Leal | |||
| P2860 | cites work | Localized cutaneous Cryptococcus albidus infection in a 14-year-old boy on etanercept therapy | Q80416861 |
| [Anti-TNF alpha therapy: a risk factor for legionella infection] | Q80447731 | ||
| Bilateral Candida chorioretinitis following etanercept treatment for hidradenitis suppurativa | Q80606014 | ||
| Etanercept: an overview of its role in the treatment of psoriasis | Q80946645 | ||
| Listeria monocytogenes septic arthritis in a patient treated with etanercept for rheumatoid arthritis | Q81632442 | ||
| Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial | Q81658198 | ||
| Fatal streptococcal toxic shock syndrome in a patient with rheumatoid arthritis treated with etanercept | Q81712901 | ||
| Etanercept monotherapy in patients with psoriasis: a summary of safety, based on an integrated multistudy database | Q82603551 | ||
| [Psoriasis and HIV infection] | Q83009631 | ||
| Relapsing oligoarticular septic arthritis during etanercept treatment of rheumatoid arthritis | Q83119225 | ||
| Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents | Q28109332 | ||
| Listeria-associated arthritis in a patient undergoing etanercept therapy: case report and review of the literature | Q33859169 | ||
| Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial | Q33976382 | ||
| Septic shock and community-acquired pneumonia associated with etanercept therapy. | Q34590217 | ||
| Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study | Q34923104 | ||
| Efficacy and safety of combination etanercept and methotrexate versus etanercept alone in patients with rheumatoid arthritis with an inadequate response to methotrexate: the ADORE study | Q35638208 | ||
| The safety of etanercept for the treatment of plaque psoriasis. | Q35919214 | ||
| Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists | Q36013844 | ||
| Infectious complications of tumor necrosis factor-alpha antagonists | Q36154725 | ||
| Mycobacterium abscessus infection after use of tumor necrosis factor alpha inhibitor therapy: case report and review of infectious complications associated with tumor necrosis factor alpha inhibitor use. | Q36296993 | ||
| Safety of etanercept in psoriasis: a critical review | Q36548668 | ||
| The impact of treatment with tumour necrosis factor-alpha antagonists on the course of chronic viral infections: a review of the literature | Q37306090 | ||
| Infectious complications with anti-TNFalpha therapy in rheumatic diseases: a review | Q37348055 | ||
| Cutaneous side effects of anti-tumor necrosis factor biologic therapy: a clinical review | Q37560336 | ||
| Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis | Q38396451 | ||
| Pneumococcal meningitis and etanercept--chance or association? | Q39136149 | ||
| Disseminated cutaneous Herpes Simplex Virus-1 in a woman with rheumatoid arthritis receiving infliximab: a case report | Q40411197 | ||
| Infectious complications associated with the use of tumor necrosis factor antagonist drugs: a review | Q40492319 | ||
| Psoriatic arthritis and hypopyon-iridocyclitis. Possible mechanism of the association of psoriasis and anterior uveitis | Q41309366 | ||
| Fatal pulmonary Mycobacterium xenopi in a patient with rheumatoid arthritis receiving etanercept | Q42262013 | ||
| Disseminated herpes zoster mimicking rheumatoid vasculitis in a rheumatoid arthritis patient on etanercept | Q43299949 | ||
| Parapharyngeal abscess in a patient receiving etanercept | Q43445519 | ||
| Cytomegalovirus complicating biological immunosuppressive therapy in two patients with psoriasis receiving treatment with etanercept or efalizumab. | Q43802101 | ||
| Multiple bilateral eyelid molluscum contagiosum lesions associated with TNFalpha-antibody and methotrexate therapy | Q44078484 | ||
| Serious infections during anti-TNFalpha treatment in rheumatoid arthritis patients. | Q44337775 | ||
| Septic arthritis due to Listeria monocytogenes in a patient receiving etanercept | Q44419791 | ||
| Infections in patients with rheumatoid arthritis treated with biologic agents | Q44952372 | ||
| Disseminated systemic Nocardia farcinica infection complicating alefacept and infliximab therapy in a patient with severe psoriasis. | Q45980332 | ||
| Pulmonary Mycobacterium szulgai infection and treatment in a patient receiving anti-tumor necrosis factor therapy. | Q53475183 | ||
| Genital HPV lesions and molluscum contagiosum occurring in patients receiving anti-TNF-alpha therapy. | Q54313559 | ||
| Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti–tumor necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register | Q56969723 | ||
| Emergence of Legionella pneumophila Pneumonia in Patients Receiving Tumor Necrosis Factor- Antagonists | Q57779961 | ||
| Directrices españolas basadas en la evidencia para el tratamiento de la psoriasis moderada a grave con agentes biológicos | Q58764407 | ||
| Tinea versicolor associated with etanercept therapy | Q59031429 | ||
| Tear film and meibomian gland functions in psoriasis | Q71710366 | ||
| Psoriatic corneal abscess | Q72324416 | ||
| Traumatic wound dehiscence after penetrating keratoplasty: clinical features and outcome in 21 cases | Q72992239 | ||
| Psoriasis, psoriatic arthropathy and relapsing orbital myositis | Q74080094 | ||
| Magnetic resonance imaging of acquired Brown syndrome in a patient with psoriasis | Q74465069 | ||
| Infections during tumour necrosis factor-alpha blocker therapy for rheumatic diseases in daily practice: a systematic retrospective study of 709 patients | Q80034808 | ||
| P304 | page(s) | 70-76 | |
| P577 | publication date | 2010-05-01 | |
| P1433 | published in | Actas Dermo-Sifiliográficas | Q15746074 |
| P1476 | title | [Etanercept and infections] | |
| P478 | volume | 101 Suppl 1 |
Search more.